BMSN JUST HIT 3 PR's TODAY!!!! SEVERELY UNDERVALUED! COMPARATIVE MARKET CAP FOR BMSN AND SIMILAR BIOTECHS VALUE BMSN AT 11.7C PPS UPON PEAK VALUE PHASE 1 CLINICAL TRIALS STARTING ANY SECOND! NEWS FOR APPROVAL IMMINENT!